Pulmonary Edema

Definition and Pathophysiology

Classification

Pathology

• Edema is initially dependent (basal lung zones)
• Histology: engorged alveolar capillaries, finely granular pale pink transudate in alveoli, microhemorrhages, hemosiderin-laden macrophages ("heart failure cells")
• Chronic congestion (e.g., mitral stenosis): abundant hemosiderin macrophages, fibrosis, thickened alveolar walls - "brown induration" - impairs gas exchange and predisposes to infection

• Inflammatory exudate leaks into interstitium and alveoli
• Protein-rich fluid (distinguishes from transudate)
• Severe form progresses to ARDS with hyaline membrane formation

Clinical Features

• Dyspnea at rest, orthopnea, paroxysmal nocturnal dyspnea (PND)
• Pink frothy sputum (alveolar flooding)
• Anxiety, diaphoresis, sense of suffocation

• Tachypnea, tachycardia
• Bilateral basal (inspiratory) crackles
• S3 gallop, elevated JVP, peripheral edema (in heart failure)
• Hypoxia (widened A-a gradient)
• In "flash" pulmonary edema: sudden onset, often hypertensive

Diagnosis

1. Vascular redistribution (upper lobe vessel prominence)
2. Kerley B lines (interstitial phase)
3. Bat-wing/"butterfly" perihilar alveolar opacities
4. Pleural effusions, cardiomegaly (in cardiogenic)

• BNP >500 pg/mL or NT-proBNP >900 pg/mL: moderately useful for establishing heart failure diagnosis
• Values 100-500 pg/mL are indeterminate
• Note: BNP can be falsely low in "flash" pulmonary edema settings

• B-lines (comet-tail artifacts) on lung ultrasound indicate interstitial edema and are more sensitive than clinical exam, especially in CKD/ESRD patients where exam findings correlate poorly with edema severity
• Recent systematic review (2025, PMID 40845678) confirms utility of POCUS for diagnosing pulmonary edema

Management

Braunwald's Heart Disease - Algorithm for management of acute heart failure based on congestion and perfusion status

1. Positioning and Oxygen

• Sit patient upright with legs dependent (reduces venous return)
• Supplemental O2 to target SpO2 ≥94%

2. Non-Invasive Ventilation (NIV)

• CPAP or BiPAP is a first-line intervention; reduces need for intubation, improves oxygenation, reduces preload, and decreases LV afterload by increasing intrathoracic pressure
• Meta-analyses show NIV (primarily CPAP) decreases intubation rate and improves mortality in cardiogenic pulmonary edema
• CPAP vs. BiPAP: no significant difference in clinical outcomes when directly compared
• Contraindications: inability to protect airway, life-threatening hypoxia requiring immediate intubation, altered sensorium, patient non-cooperation

3. Loop Diuretics

• Furosemide (0.5 mg/kg IV; up to 1 mg/kg if renal insufficiency/chronic diuretic use) is first-line - it acts as a venodilator rapidly before diuresis begins
• Over 75% of AHF emergency patients receive IV diuretics; mean door-to-diuretic time ~2.2 hours in the ADHERE registry
• Continuous infusion or combination diuretics for diuretic resistance
• If hypotensive or in cardiogenic shock: diuretics are of limited benefit; ultrafiltration preferred

4. Vasodilators (Nitrates)

• Sublingual nitroglycerin 0.4 mg q5 min × 3 is first-line for acute cardiogenic pulmonary edema
• If persistent without hypotension: IV nitroglycerin starting at 5-10 μg/min (up to 300+ μg/min)
• Early IV nitrate therapy in severe cardiogenic pulmonary edema reduces need for mechanical ventilation and frequency of MI
• IV nitroprusside (0.1-5 μg/kg/min): potent arteriovenous dilator for pulmonary edema with hypertension; requires arterial line monitoring; avoid in reduced coronary perfusion states
• ACE inhibitors: reduce preload and afterload; beneficial in hypertensive patients and post-MI heart failure
• A 2025 systematic review (PMID 40506079) supports high-dose IV nitroglycerin in sympathetic crashing acute pulmonary edema

5. Morphine - Controversial

• Historically used (2-4 mg IV) for vasodilation and dyspnea relief
• Retrospective registry data shows association with increased mortality (increased intubation, ICU admission, prolonged stay)
• European Society of Cardiology recommends against routine use; AHA/ACC discusses morphine only in palliative context
• Use with caution if at all; only in severe refractory dyspnea

6. Inotropic/Inodilator Drugs (Cardiogenic Shock)

• Indicated when pulmonary edema accompanies hypotension/cardiogenic shock
• Dobutamine, dopamine (sympathomimetic amines): temporary inotropic support
• Milrinone (phosphodiesterase-3 inhibitor, 50 μg/kg load → 0.25-0.75 μg/kg/min): inotropic + vasodilator; useful in severe LV dysfunction
• Not recommended for patients with depressed EF and pulmonary edema but without hypotension or impaired perfusion (may be harmful)

7. Renal Replacement Therapy

• Indicated for refractory volume overload, metabolic acidosis (pH <7.15-7.25), persistent hyperkalemia, or severe hypoxemia unresponsive to pharmacotherapy
• In CKD/ESRD: hemodialysis is the most rapidly effective treatment (peritoneal dialysis too slow)
• Continuous renal replacement therapy (CVVH) preferred when patient is hypotensive or requiring vasopressors

8. Intubation and Mechanical Ventilation

• Required in ~4-5% of all AHF patients
• Indications: failure of NIV, inability to protect airway, life-threatening hypoxia

Special Clinical Situations

High-Altitude Pulmonary Edema (HAPE)

• Non-cardiogenic, caused by hypoxic pulmonary vasoconstriction
• Treatment: descent + oxygen (definitive); nifedipine (calcium channel blocker) is useful pharmacologically; phosphodiesterase-5 inhibitors (sildenafil/tadalafil) are alternatives
• Furosemide and nitroglycerin are not first-line

Neurogenic Pulmonary Edema

• Follows CNS trauma/SAH; catecholamine surge causes massive increase in pulmonary capillary pressure and permeability
• Management: treat underlying CNS pathology; supportive care

CKD/ESRD-Associated Pulmonary Edema

• Etiology is often multifactorial: increased hydrostatic pressure (fluid overload/CHF) + reduced oncotic pressure (hypoalbuminemia) + increased permeability (uremia)
• Dialysis is the most effective treatment; standard diuretics often ineffective
• Physical exam findings (crackles, edema) correlate poorly with actual degree of interstitial edema in this population

Physiology Summary (Key Numbers)

Guyton & Hall - Edema formation accelerates sharply once left atrial pressure exceeds the plasma colloid osmotic pressure (~25 mmHg)

• Guyton and Hall Textbook of Medical Physiology (physiology/safety factors)
• Robbins, Cotran & Kumar Pathologic Basis of Disease (classification/pathology)
• Harrison's Principles of Internal Medicine 22E (management/pharmacology)
• Braunwald's Heart Disease (AHF hemodynamic profiles/algorithm)
• Murray & Nadel's Textbook of Respiratory Medicine (pharmacologic therapy)
• Fishman's Pulmonary Diseases and Disorders (NIV evidence)
• Tintinalli's Emergency Medicine (BNP thresholds/CKD)

• PMID 40506079 (2025 meta-analysis): High-dose IV nitroglycerin in sympathetic crashing acute pulmonary edema is supported
• PMID 40845678 (2025 systematic review): Point-of-care ultrasound (B-lines) is a reliable diagnostic tool for pulmonary edema